A Review on the Immunological Response against Trypanosoma cruzi

G Macaluso, F Grippi, S Di Bella, V Blanda, F Gucciardi… - Pathogens, 2023 - mdpi.com
Chagas disease is a chronic systemic infection transmitted by Trypanosoma cruzi. Its life
cycle consists of different stages in vector insects and host mammals. Trypanosoma cruzi …

[HTML][HTML] Immunity and vaccine development efforts against Trypanosoma cruzi

LE Rios, JC Vázquez-Chagoyán, AO Pacheco… - Acta tropica, 2019 - Elsevier
Trypanosoma cruzi (T. cruzi) is the causative agent for Chagas disease (CD). There is a
critical lack of methods for prevention of infection or treatment of acute infection and chronic …

Immunization with lipopolysaccharide-activated dendritic cells generates a specific CD8+ T cell response that confers partial protection against infection with …

L Biscari, CD Kaufman, C Farré, V Huhn… - Frontiers in Cellular …, 2022 - frontiersin.org
Lipopolysaccharide (LPS) induces the activation of dendritic cells (DCs) throughout the
engagement of toll-like receptor 4. LPS-activated DCs show increased capacity to process …

Determining seropositivity—A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases

YY Chan, K Fornace, L Wu, BF Arnold… - PLoS neglected …, 2021 - journals.plos.org
Background Serological surveys with multiplex bead assays can be used to assess
seroprevalence to multiple pathogens simultaneously. However, multiple methods have …

Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine

KM Jones, C Poveda, L Versteeg… - Expert review of …, 2022 - Taylor & Francis
Introduction Chronic infection with the protozoal parasite Trypanosoma cruzi leads to a
progressive cardiac disease, known as chronic Chagasic cardiomyopathy (CCC). A new …

Host‐parasite dynamics in Chagas disease from systemic to hyper‐local scales

D Pérez‐Mazliah, AI Ward, MD Lewis - Parasite immunology, 2021 - Wiley Online Library
Trypanosoma cruzi is a remarkably versatile parasite. It can parasitize almost any nucleated
cell type and naturally infects hundreds of mammal species across much of the Americas. In …

The oxidative stress and chronic inflammatory process in Chagas disease: role of exosomes and contributing genetic factors

E Maldonado, DA Rojas, F Urbina… - Oxidative Medicine and …, 2021 - Wiley Online Library
Chagas disease is a neglected tropical disease caused by the flagellated protozoa
Trypanosoma cruzi that affects several million people mainly in Latin American countries …

Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease

I Gómez, MC López, A Egui, G Palacios… - PLOS Neglected …, 2023 - journals.plos.org
Background Patients with chronic Chagas disease present marked clinical and
immunological heterogeneity. During the disease, multiple immune mechanisms are …

Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease

I Carrillo, RAN Rabelo, C Barbosa… - PLoS Neglected …, 2021 - journals.plos.org
Background Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in
Latin America and is widely distributed worldwide because of migration. In 30% of cases …

Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes

I Molina, MS Marcolino, MC Pires, LEF Ramos… - Scientific Reports, 2021 - nature.com
Chagas disease (CD) continues to be a major public health burden in Latina America.
Information on the interplay between COVID-19 and CD is lacking. Our aim was to assess …